What happened
In the last few weeks, the aesthetic industry has been talking about one thing. A clinical review published in late July looked at whether so called Ozempic face is changing aesthetic practice, and the numbers behind it are striking: in the latest survey of the American Academy of Facial Plastic and Reconstructive Surgery, two thirds of facial plastic surgeons reported a rise in patients seeking treatment for facial changes after rapid weight loss. Days later, the CEO of one of the largest injectable manufacturers told financial media that GLP-1 users are now a major growth engine for filler and toxin sales.
Read those two facts together and you see the problem. Millions of people are losing weight faster than their faces can adapt, and the loudest answer they are being offered is a syringe.
What people get wrong
The common assumption is that Ozempic face is a volume problem, so the fix must be volume: filler, biostimulators, a few sessions, done. The injectable industry has every commercial reason to encourage this belief.
The clinical reality
Significant weight loss changes the face in two separate ways, and only one of them responds to volume. Yes, the deep and superficial fat compartments deflate. But the skin envelope and the retaining ligaments also stretch and lose recoil, which is a structural problem, not a volume problem. I explained the mechanism in detail on my Ozempic face page; the short version is that a deflated balloon does not become a new balloon when you add air.
In a patient who has lost fifteen kilograms or more, filling a lax face often produces the heavy, overfilled look patients fear most, because the product sits in tissue that can no longer hold it in position. When laxity is the dominant finding, repositioning the tissue surgically, in the correct anatomical plane, is the honest answer. That is what a deep plane facelift does, often combined with structural fat grafting to restore the volume component at the same operation. When the main issue is skin quality rather than descent, energy based treatments such as Fotona laser protocols have a real role, and they cost far less than chasing laxity with repeated filler sessions.
What this means for you
If you are on a GLP-1 medication and unhappy with your face, the first question is not which treatment to book. It is where you are on your weight curve. Ask yourself three things. Has my weight been stable for at least three to six months? Do I plan to stay on the medication, and at what dose? Is my main complaint hollowness, sagging, or skin texture? The answers determine whether you need volume, repositioning, resurfacing, or simply patience. The surgical societies are moving in the same direction: a new review announced by the American Society of Plastic Surgeons this month recommends nutrition screening and a personalized diet plan before body contouring surgery in patients with significant weight loss, precisely because a body that has lost mass rapidly heals differently. A consultation photo taken mid weight loss is a snapshot of a moving target.
The honest boundary
I do not operate on patients who are still actively losing weight, and I tell them so in the first consultation. A facelift performed on a face that will lose another ten kilograms of overlying change is a facelift that will need revision, and revision surgery carries more risk than primary surgery. Surgeons who operate mid curve are treating the calendar, not the patient. If your weight is not stable, the right plan today may be no procedure at all, and any clinic that tells you otherwise is answering a commercial question, not a clinical one. You can see what a properly timed result looks like in my deep plane facelift case study.
Dr. Mustafa Aydınol is a plastic, reconstructive and aesthetic surgeon practicing in Istanbul, and a member of the International Society of Aesthetic Plastic Surgery (ISAPS) and the Turkish Society of Plastic, Reconstructive and Aesthetic Surgeons. If you would like to discuss your own situation, you can reach the clinic on WhatsApp at +90 544 772 0772.
